Medline Announces Significant Leadership Changes for Future Growth

Medline's Leadership Transition: A New Era Begins

Medline Industries, a leader in medical-surgical products and supply chain solutions, recently made headlines with pivotal leadership changes set to take effect in 2025. As the company prepares for these transitions, insider perspectives reveal a transformative moment in Medline's journey.

Jim Pigott, the current President and Chief Operating Officer (COO), has decided to retire at the end of 2025 after a prolific tenure that began in 1992. His leadership has been instrumental in propelling Medline to its status as a market leader, characterized by consistent growth and expanded reach within the healthcare sector.

In his announcement, Medline's CEO, Jim Boyle, expressed profound appreciation for Pigott’s contributions, noting that his strategic vision and operational expertise significantly shaped Medline's success. As the company ventures into a new chapter, Pigott's presence will be revered, and his support through the transition emphasizes Medline's commitment to stability during this period of change.

Transitioning into Pigott's former roles will be Amanda Laabs and Steve Miller, two seasoned executives with deep-rooted knowledge and experience within the company. Both have showcased their entrepreneurial spirit and customer-centric approach, which are vital as Medline navigates its future endeavors.

Laabs, promoted to Chief Product Officer, steps into her new position after serving as the Executive Vice President of Medline Brands. She joined Medline in 2006 and has progressively held various product management roles, exemplifying her capability to lead product divisions and manage international markets effectively. Under her leadership, Medline aims to bolster its product offerings and drive innovation in healthcare solutions.

Meanwhile, Steve Miller assumes the role of the new COO. His extensive background as EVP of Supply Chain will now encompass oversight of IT, Inventory Management, and Quality, expanding his responsibilities within Medline's operations. Prior to his time at Medline, Miller’s broad experience included key management roles at Walmart, Goodyear, and Kimberly-Clark, particularly in operations and supply chain management—an asset that will undoubtedly enhance Medline's operational efficiency moving forward.

With more than $23 billion in annual sales and a workforce of 43,000 employees globally, Medline's reputation for delivering superior medical products and service solutions is unparalleled. The company operates across over 100 countries, catering to all facets of healthcare delivery.

The leadership sequence reflects Medline’s strategic objectives as it seeks to enhance patient care through improved clinical and operational outcomes. By nurturing a world-class team led by Laabs and Miller, Medline is poised for continued success in the evolving landscape of healthcare.

As the industry shifts dynamically, these leadership changes at Medline mark both an ending and a new beginning, with strong leaders at the helm ready to guide the company toward a promising future.

For more information about Medline and its solutions, visit Medline's Official Website.